Drug recall D-0389-2024
Product
Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20
Reason for recall
Cross Contamination with Other Products:(mycophenolate mofetil).
Lots and codes
Lot #: M23172A, Exp 01/31/2025
Recall details
- Recalling firm
- Novitium Pharma LLC, East Windsor, NJ
- Quantity
- 3,940 1000-count bottles
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 4, 2024
- Terminated
- March 21, 2025
Related products
- Digoxin – drug information
- NDC 70954-201 Digoxin · Digoxin .125 mg/1 · ANI Pharmaceuticals, Inc.
- NDC 70954-200 Digoxin · Digoxin .0625 mg/1 · ANI Pharmaceuticals, Inc.
- NDC 70954-202 Digoxin · Digoxin .25 mg/1 · ANI Pharmaceuticals, Inc.